Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-25-001166

Chief Financial Officer acquired 188,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Gabay Avraham Chief Financial Officer 2025-01-02 Grant or award +188,000 358,040 D
Loading xslF345X05/ownership.xml…